Apheresis Market by Product (Devices, Disposable & Reagents, and Software), Method (Centrifugation, Membrane Separation, and Selective Adsorption), Procedure (Donor/Automated Apheresis and Therapeutic Apheresis), Component {Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis), Lymphocytes (Lymph Apheresis), and RBCs (Erythropheresis)}, and End User (Blood Centers, Hospitals, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

April 2018 | 290 pages | ID: A03F1C0A067EN
Allied Market Research

Abstracts

The global apheresis market was valued at $2,560.4 million in 2016, and is expected to reach $4,200.6 million by 2023, registering a CAGR of 7.3% from 2017 to 2023. Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient.
Use of large-scale plasma donations in the treatment of trauma patients, burn victims, and patients suffering from serious illness or injuries primarily contributes towards the growth of the apheresis market. In addition, rise in prevalence of cancer and surge in number of patients undergoing surgery have increased the number of plateletpheresis across the globe, thereby supplementing the market growth. However, dearth of skilled professionals and post-procedural complications associated with apheresis are anticipated to hamper the market growth. On the contrary, advancements in the healthcare sector in emerging economies are expected to offer significant profitable opportunities for the market players.
The global apheresis market is segmented based on product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). The end users covered in the study include blood centers, hospitals, and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS

• The study provides an in-depth analysis of the global apheresis market with the current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of the factors that drive and restrict the market growth is provided.
• Comprehensive quantitative analysis of the industry is provided from 2016 to 2023 to assist stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the trends in apheresis globally.
• Key players and their strategies are provided to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product

• Devices
• Disposable & Reagents
• Software

By Method

• Centrifugation
• Intermittent Flow Centrifugation
• Continuous Flow Centrifugation
• Membrane Separation
• Selective Adsorption

By Procedure

• Donor/Automated Apheresis
• Therapeutic Apheresis
• Type
• Plasma Exchange
• Stem Cell Harvest
• Photopheresis
• Low Density Lipid Removal
• Other Procedures
• Application
• Hematology
• Neurology
• Oncology
• Others

By Component

• Plasma (Plasmapheresis)
• Platelets (Plateletpheresis)
• Leukocytes (Leukapheresis)
• Lymphocytes (Lymph Apheresis)
• RBCs (Erythropheresis)

By End User

• Blood Centers
• Hospitals
• Other End Users

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• France
• Germany
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Turkey
• Saudi Arabia
• Rest of LAMEA

KEY MARKET PLAYERS

• Haemonetics Corporation
• Fresenius Kabi
• Terumo BCT, Inc.
• Asahi Kasei Medical Co., Ltd.
• HemaCare Corporation
• Kaneka Corporation
• Kawasumi Laboratories Inc.
• Cerus Corporation
• B. Braun Melsungen AG
• Nikkiso Co., Ltd.

The other players in the value chain include (profiles not included in the report)

• Grifols International SA
• Baxter International Inc.
• CSL Behring
• Immucor
• Becton, Dickinson & Co.
• Abbott Laboratories
• Medicap
• Bioelettronica

Contents

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
  3.2.1. Top winning strategies
  3.2.2. Top investment pockets
3.3. Porters five forces analysis
3.4. Market share analysis
3.5. Market dynamics
  3.5.1. Drivers
    3.5.1.1. Soaring demand for blood components across the globe
    3.5.1.2. Increase in the government initiatives regarding blood donation
    3.5.1.3. Newly approved indications for apheresis treatment
  3.5.2. Restraints
    3.5.2.1. Dearth of skilled professionals
    3.5.2.2. Complications associated with the apheresis procedure
  3.5.3. Opportunity
    3.5.3.1. Rise in the demand for plasma-derived pharmaceuticals

CHAPTER 4: APHERESIS MARKET BY PRODUCT

4.1. Overview
  4.1.1. Market size and forecast
4.2. Devices
  4.2.1. Key trends and opportunities
  4.2.2. Market size and forecast
  4.2.3. Market analysis, by country
4.3. Disposables & Reagents
  4.3.1. Key trends and opportunities
  4.3.2. Market size and forecast
  4.3.3. Market analysis, by country
4.4. Software
  4.4.1. Key trends and opportunities
  4.4.2. Market size and forecast
  4.4.3. Market analysis, by country

CHAPTER 5: APHERESIS MARKET BY PROCEDURE

5.1. Overview
  5.1.1. Market size and forecast
5.2. Donor/Automated Apheresis
  5.2.1. Market size and forecast
  5.2.2. Market analysis, by country
5.3. Therapeutic Apheresis
  5.3.1. Market size and forecast
  5.3.2. Market analysis, by country
  5.3.3. Therapeutic Apheresis Market by Type
    5.3.3.1. Market size and forecast
    5.3.3.2. Plasma Exchange
      5.3.3.2.1. Market size and forecast
    5.3.3.3. Stem Cell Harvest
      5.3.3.3.1. Market size and forecast
    5.3.3.4. Photopheresis
      5.3.3.4.1. Market size and forecast
    5.3.3.5. Low Density Lipid Removal
      5.3.3.5.1. Market size and forecast
    5.3.3.6. Other Therapeutic Type
      5.3.3.6.1. Market size and forecast
  5.3.4. Therapeutic Apheresis Market by Specialty
    5.3.4.1. Market size and forecast
    5.3.4.2. Hematology
      5.3.4.2.1. Market size and forecast
    5.3.4.3. Neurology
      5.3.4.3.1. Market size and forecast
    5.3.4.4. Oncology
      5.3.4.4.1. Market size and forecast
    5.3.4.5. Other Therapeutic Application
      5.3.4.5.1. Market size and forecast

CHAPTER 6: APHERESIS MARKET BY METHOD

6.1. Overview
  6.1.1. Market size and forecast
6.2. Centrifugation
  6.2.1. Market size and forecast
  6.2.2. Market analysis, by country
  6.2.3. Intermittent Flow Centrifugation
    6.2.3.1. Market size and forecast
  6.2.4. Continuous Flow Centrifugation
    6.2.4.1. Market size and forecast
6.3. Membrane Separation
  6.3.1. Market size and forecast
  6.3.2. Market analysis, by country
6.4. Selective Adsorption
  6.4.1. Market size and forecast
  6.4.2. Market analysis, by country

CHAPTER 7: APHERESIS MARKET BY COMPONENT

7.1. Overview
  7.1.1. Market size and forecast
7.2. Plasma (Plasmapheresis)
  7.2.1. Market size and forecast
  7.2.2. Market analysis, by country
7.3. Platelets (Plateletpheresis)
  7.3.1. Market size and forecast
  7.3.2. Market analysis, by country
7.4. Leukocytes (Leukapheresis)
  7.4.1. Market size and forecast
  7.4.2. Market analysis, by country
7.5. Lymphocytes (Lymph apheresis)
  7.5.1. Market size and forecast
  7.5.2. Market analysis, by country
7.6. RBC's (Erythropheresis)
  7.6.1. Market size and forecast
  7.6.2. Market analysis, by country

CHAPTER 8: APHERESIS MARKET BY END USER

8.1. Overview
  8.1.1. Market size and forecast
8.2. Blood Centers
  8.2.1. Market size and forecast
  8.2.2. Market analysis, by country
8.3. Hospitals
  8.3.1. Market size and forecast
  8.3.2. Market analysis, by country
8.4. Other end users
  8.4.1. Market size and forecast
  8.4.2. Market analysis, by country

CHAPTER 9: APHERESIS MARKET BY REGION

9.1. Overview
  9.1.1. Market size and forecast
9.2. North America
  9.2.1. Key trends and opportunities
  9.2.2. North America market size & forecast by country
  9.2.3. North America market size & forecast by product
  9.2.4. North America market size & forecast by method
  9.2.5. North America market size & forecast by procedure
  9.2.6. North America market size & forecast by component
  9.2.7. North America market size & forecast by end user
    9.2.7.1. U.S. market size & forecast by product
    9.2.7.2. U.S. market size & forecast by method
    9.2.7.3. U.S. market size & forecast by procedure
    9.2.7.4. U.S. market size & forecast by component
    9.2.7.5. U.S. market size & forecast by end user
    9.2.7.6. Canada market size & forecast by product
    9.2.7.7. Canada market size & forecast by method
    9.2.7.8. Canada market size & forecast by procedure
    9.2.7.9. Canada market size & forecast by component
    9.2.7.10. Canada market size & forecast by end user
    9.2.7.11. Mexico market size & forecast by product
    9.2.7.12. Mexico market size & forecast by method
    9.2.7.13. Mexico market size & forecast by procedure
    9.2.7.14. Mexico market size & forecast by component
    9.2.7.15. Mexico market size & forecast by end user
9.3. Europe
  9.3.1. Key trends and opportunities
  9.3.2. Europe market size & forecast for apheresis market by country
  9.3.3. Europe market size & forecast by product
  9.3.4. Europe market size & forecast by method
  9.3.5. Europe market size & forecast by procedure
  9.3.6. Europe market size & forecast by component
  9.3.7. Europe market size & forecast by end user
    9.3.7.1. Germany market size & forecast by product
    9.3.7.2. Germany market size & forecast by method
    9.3.7.3. Germany market size & forecast by procedure
    9.3.7.4. Germany market size & forecast by component
    9.3.7.5. Germany market size & forecast by end user
    9.3.7.6. France market size & forecast by product
    9.3.7.7. France market size & forecast by method
    9.3.7.8. France market size & forecast by procedure
    9.3.7.9. France market size & forecast by component
    9.3.7.10. France market size & forecast by end user
    9.3.7.11. UK market size & forecast by product
    9.3.7.12. UK market size & forecast by method
    9.3.7.13. UK market size & forecast by procedure
    9.3.7.14. UK market size & forecast by component
    9.3.7.15. UK market size & forecast by end user
    9.3.7.16. Italy market size & forecast by product
    9.3.7.17. Italy market size & forecast by method
    9.3.7.18. Italy market size & forecast by procedure
    9.3.7.19. Italy market size & forecast by component
    9.3.7.20. Italy market size & forecast by end user
    9.3.7.21. Spain market size & forecast by product
    9.3.7.22. Spain market size & forecast by method
    9.3.7.23. Spain market size & forecast by procedure
    9.3.7.24. Spain market size & forecast by component
    9.3.7.25. Spain market size & forecast by end user
    9.3.7.26. Rest of Europe market size & forecast by product
    9.3.7.27. Rest of Europe market size & forecast by method
    9.3.7.28. Rest of Europe market size & forecast by procedure
    9.3.7.29. Rest of Europe market size & forecast by component
    9.3.7.30. Rest of Europe market size & forecast by end user
9.4. Asia-Pacific
  9.4.1. Key trends and opportunities
  9.4.2. Asia-Pacific market size & forecast by country
  9.4.3. Asia-Pacific market size & forecast by product
  9.4.4. Asia-Pacific market size & forecast by method
  9.4.5. Asia-Pacific market size & forecast by procedure
  9.4.6. Asia-Pacific market size & forecast by component
  9.4.7. Asia-Pacific market size & forecast by end user
    9.4.7.1. Japan market size & forecast by product
    9.4.7.2. Japan market size & forecast by method
    9.4.7.3. Japan market size & forecast by procedure
    9.4.7.4. Japan market size & forecast by component
    9.4.7.5. Japan market size & forecast by end user
    9.4.7.6. China market size & forecast by product
    9.4.7.7. China market size & forecast by method
    9.4.7.8. China market size & forecast by procedure
    9.4.7.9. China market size & forecast by component
    9.4.7.10. China market size & forecast by end user
    9.4.7.11. India market size & forecast by product
    9.4.7.12. India market size & forecast by method
    9.4.7.13. India market size & forecast by procedure
    9.4.7.14. India market size & forecast by component
    9.4.7.15. India market size & forecast by end user
    9.4.7.16. Australia market size & forecast by product
    9.4.7.17. Australia market size & forecast by method
    9.4.7.18. Australia market size & forecast by procedure
    9.4.7.19. Australia market size & forecast by component
    9.4.7.20. Australia market size & forecast by end user
    9.4.7.21. Rest of Asia-Pacific market size & forecast by product
    9.4.7.22. Rest of Asia-Pacific market size & forecast by method
    9.4.7.23. Rest of Asia-Pacific market size & forecast by procedure
    9.4.7.24. Rest of Asia-Pacific market size & forecast by component
    9.4.7.25. Rest of Asia-Pacific market size & forecast by end user
9.5. LAMEA
  9.5.1. Key trends and opportunities
  9.5.2. LAMEA market size & forecast by country
  9.5.3. LAMEA market size & forecast by product
  9.5.4. LAMEA market size & forecast by method
  9.5.5. LAMEA market size & forecast by procedure
  9.5.6. LAMEA market size & forecast by component
  9.5.7. LAMEA market size & forecast by end user
    9.5.7.1. Brazil market size & forecast by product
    9.5.7.2. Brazil market size & forecast by method
    9.5.7.3. Brazil market size & forecast by procedure
    9.5.7.4. Brazil market size & forecast by component
    9.5.7.5. Brazil market size & forecast by end user
    9.5.7.6. South Africa market size & forecast by product
    9.5.7.7. South Africa market size & forecast by method
    9.5.7.8. South Africa market size & forecast by procedure
    9.5.7.9. South Africa market size & forecast by component
    9.5.7.10. South Africa market size & forecast by end user
    9.5.7.11. Turkey market size & forecast by product
    9.5.7.12. Turkey market size & forecast by method
    9.5.7.13. Turkey market size & forecast by procedure
    9.5.7.14. Turkey market size & forecast by component
    9.5.7.15. Turkey market size & forecast by end user
    9.5.7.16. Saudi Arabia market size & forecast by product
    9.5.7.17. Saudi Arabia market size & forecast by method
    9.5.7.18. Saudi Arabia market size & forecast by procedure
    9.5.7.19. Saudi Arabia market size & forecast by component
    9.5.7.20. Saudi Arabia market size & forecast by end user
    9.5.7.21. Rest of LAMEA market size & forecast by product
    9.5.7.22. Rest of LAMEA market size & forecast by method
    9.5.7.23. Rest of LAMEA market size & forecast by procedure
    9.5.7.24. Rest of LAMEA market size & forecast by component
    9.5.7.25. Rest of LAMEA market size & forecast by end user

CHAPTER 10: COMPANY PROFILE

10.1. Haemonetics Corporation
  10.1.1. Company overview
  10.1.2. Company snapshot
  10.1.3. Operating business segments
  10.1.4. Business performance
  10.1.5. Key strategic moves and developments
10.2. Fresenius Kabi
  10.2.1. Company overview
  10.2.2. Company snapshot
  10.2.3. Operating business segments
  10.2.4. Business performance
  10.2.5. Key strategic moves and developments
10.3. Terumo BCT, Inc.
  10.3.1. Company overview
  10.3.2. Company snapshot
  10.3.3. Operating business segments
  10.3.4. Business performance
  10.3.5. Key strategic moves and developments
10.4. Asahi Kasei Medical Co., Ltd.
  10.4.1. Company overview
  10.4.2. Company snapshot
  10.4.3. Operating business segments
  10.4.4. Business performance
  10.4.5. Key strategic moves and developments
10.5. HemaCare Corporation
  10.5.1. Company overview
  10.5.2. Company snapshot
  10.5.3. Operating business segments
  10.5.4. Business performance
  10.5.5. Key strategic moves and developments
10.6. Kaneka Corporation
  10.6.1. Company overview
  10.6.2. Company snapshot
  10.6.3. Operating business segments
  10.6.4. Business performance
  10.6.5. Key strategic moves and developments
10.7. Kawasumi Laboratories Inc.
  10.7.1. Company overview
  10.7.2. Company snapshot
  10.7.3. Operating business segments
  10.7.4. Business performance
  10.7.5. Key strategic moves and developments
10.8. Cerus Corporation
  10.8.1. Company overview
  10.8.2. Company snapshot
  10.8.3. Operating business segments
  10.8.4. Business performance
  10.8.5. Key strategic moves and developments
10.9. B. Braun Melsungen AG
  10.9.1. Company overview
  10.9.2. Company snapshot
  10.9.3. Operating business segments
  10.9.4. Business performance
  10.9.5. Key strategic moves and developments
10.10. Nikkiso Co., Ltd.
  10.10.1. Company overview
  10.10.2. Company snapshot
  10.10.3. Operating business segments
  10.10.4. Business performance
  10.10.5. Key strategic moves and developments

List Of Tables

LIST OF TABLES

TABLE 01. HAEMONETICS CORPORATION: APHERESIS PRODUCTS
TABLE 02. GLOBAL APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 03. FEW APHERESIS DEVICES IN THE MARKET
TABLE 04. GLOBAL APHERESIS MARKET FOR DEVICES, BY REGION, 2016-2023 ($MILLION)
TABLE 05. GLOBAL APHERESIS MARKET FOR DISPOSABLES & REAGENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 06. GLOBAL APHERESIS MARKET FOR SOFTWARE, BY REGION, 2016-2023 ($MILLION)
TABLE 07. GLOBAL APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 08. GLOBAL DONOR/AUTOMATED APHERESIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 09. GLOBAL THERAPEUTIC APHERESIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL THERAPEUTIC APHERESIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. GLOBAL THERAPEUTIC APHERESIS MARKET, BY SPECIALTY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 13. GLOBAL APHERESIS MARKET FOR CENTRIFUGATION, BY REGION, 2016-2023 ($MILLION)
TABLE 14. INTERMITTENT FLOW CENTRIFUGATION BASED APHERESIS SYSTEMS
TABLE 15. CONTINUOUS FLOW CENTRIFUGATION BASED APHERESIS SYSTEMS
TABLE 16. GLOBAL APHERESIS MARKET FOR MEMBRANE SEPARATION, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL APHERESIS MARKET FOR ADSORPTION COLUMN, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 19. GLOBAL APHERESIS MARKET FOR PLASMA (PLASMAPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL APHERESIS MARKET FOR PLATELETS (PLATELETPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL APHERESIS MARKET FOR LEUKOCYTES (LEUKAPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL APHERESIS MARKET FOR LYMPHOCYTES (LYMPH APHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL APHERESIS MARKET FOR RBC'S (ERYTHROPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 25. GLOBAL APHERESIS MARKET FOR BLOOD CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL APHERESIS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL APHERESIS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 ($MILLION)
TABLE 28. GLOBAL APHERESIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. U.S. APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 36. U.S. APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 37. U.S. APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 38. U.S. APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 39. U.S. APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 40. CANADA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 41. CANADA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 42. CANADA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 43. CANADA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 44. CANADA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. MEXICO APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 46. MEXICO APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 47. MEXICO APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 48. MEXICO APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 49. MEXICO APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 50. PLATELET PRODUCTION IN THE EUROPEAN COUNTRIES, 2013
TABLE 51. EUROPE APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 52. EUROPE APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 53. EUROPE APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 54. EUROPE APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 55. EUROPE APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 56. EUROPE APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 57. GERMANY APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 58. GERMANY APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 59. GERMANY APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 60. GERMANY APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 61. GERMANY APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 62. FRANCE APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 63. FRANCE APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 64. FRANCE APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 65. FRANCE APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 66. FRANCE APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 67. UK APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 68. UK APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 69. UK APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 70. UK APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 71. UK APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 72. ITALY APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 73. ITALY APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 74. ITALY APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 75. ITALY APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 76. ITALY APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 77. SPAIN APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 78. SPAIN APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 79. SPAIN APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 80. SPAIN APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 81. SPAIN APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 82. REST OF EUROPE APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 83. REST OF EUROPE APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 84. REST OF EUROPE APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 85. REST OF EUROPE APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 86. REST OF EUROPE APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 87. ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 88. ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 89. ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 90. ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 91. ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 92. ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 93. JAPAN APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 94. JAPAN APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 95. JAPAN APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 96. JAPAN APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 97. JAPAN APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 98. CHINA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 99. CHINA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 100. CHINA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 101. CHINA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 102. CHINA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 103. INDIA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 104. INDIA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 105. INDIA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 106. INDIA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 107. INDIA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 108. AUSTRALIA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 109. AUSTRALIA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 110. AUSTRALIA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 111. AUSTRALIA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 112. AUSTRALIA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 113. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 114. REST OF ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 115. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 116. REST OF ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 117. REST OF ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 118. LAMEA APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 119. LAMEA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 120. LAMEA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 121. LAMEA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 122. LAMEA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 123. LAMEA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 124. BRAZIL APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 125. BRAZIL APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 126. BRAZIL APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 127. BRAZIL APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 128. BRAZIL APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 129. SOUTH AFRICA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 130. SOUTH AFRICA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 131. SOUTH AFRICA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 132. SOUTH AFRICA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 133. SOUTH AFRICA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 134. TURKEY APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 135. TURKEY APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 136. TURKEY APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 137. TURKEY APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 138. TURKEY APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 139. SAUDI ARABIA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 140. SAUDI ARABIA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 141. SAUDI ARABIA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 142. SAUDI ARABIA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 143. SAUDI ARABIA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 144. REST OF LAMEA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 145. REST OF LAMEA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 146. REST OF LAMEA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 147. REST OF LAMEA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 148. REST OF LAMEA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 149. HAEMONETICS: COMPANY SNAPSHOT
TABLE 150. HAEMONETICS: OPERATING SEGMENTS
TABLE 151. FRESENIUS: COMPANY SNAPSHOT
TABLE 152. FRESENIUS: OPERATING SEGMENTS
TABLE 153. TERUMO: COMPANY SNAPSHOT
TABLE 154. TERUMO: OPERATING SEGMENTS
TABLE 155. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 156. ASAHI KASEI: OPERATING SEGMENTS
TABLE 157. HEMACARE: COMPANY SNAPSHOT
TABLE 158. HEMACARE: OPERATING SEGMENTS
TABLE 159. KANEKA: COMPANY SNAPSHOT
TABLE 160. KANEKA: OPERATING SEGMENTS
TABLE 161. KAWASUMI: COMPANY SNAPSHOT
TABLE 162. KAWASUMI: OPERATING SEGMENTS
TABLE 163. CERUS: COMPANY SNAPSHOT
TABLE 164. CERUS: OPERATING SEGMENTS
TABLE 165. B. BRAUN: COMPANY SNAPSHOT
TABLE 166. B. BRAUN: OPERATING SEGMENTS
TABLE 167. NIKKISO: COMPANY SNAPSHOT
TABLE 168. NIKKISO: OPERATING SEGMENTS

List Of Figures

LIST OF FIGURES

FIGURE 01. SEGMENTATION OF APHERESIS MARKET
FIGURE 02. TOP INVESTMENT POCKETS IN APHERESIS MARKET, 2016
FIGURE 03. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04. HIGH BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE THREAT OF SUBSTITUTION
FIGURE 06. HIGH THREAT OF NEW ENTRANT
FIGURE 07. HIGH COMPETITIVE RIVALRY
FIGURE 08. MARKET SHARE ANALYSIS, 2016
FIGURE 09. RESTRAINTS, DRIVERS, AND OPPORTUNITY: GLOBAL APHERESIS MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR DEVICES, BY COUNTRY, 2016 & 2023 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR DISPOSABLES & REAGENTS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR SOFTWARE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DONOR/AUTOMATED APHERESIS MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF THERAPEUTIC APHERESIS MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL STEM CELL HARVEST MARKET, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL PHOTOPHERESIS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL LOW-DENSITY LIPID REMOVAL MARKET, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL OTHER THERAPEUTIC TYPE MARKET, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL THERAPEUTIC APHERESIS MARKET FOR HEMATOLOGY, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL THERAPEUTIC APHERESIS MARKET FOR NEUROLOGY, 2016-2023 ($MILLION)
FIGURE 22. GLOBAL THERAPEUTIC APHERESIS MARKET FOR ONCOLOGY, 2016-2023 ($MILLION)
FIGURE 23. GLOBAL APHERESIS MARKET FOR OTHER THERAPEUTIC APPLICATION, 2016-2023 ($MILLION)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR CENTRIFUGATION, BY COUNTRY, 2016 & 2023 (%)
FIGURE 25. GLOBAL APHERESIS MARKET FOR INTERMITTENT FLOW CENTRIFUGATION, 2016-2023 ($MILLION)
FIGURE 26. GLOBAL APHERESIS MARKET FOR CONTINUOUS FLOW CENTRIFUGATION, 2016-2023 ($MILLION)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR MEMBRANE SEPARATION, BY COUNTRY, 2016 & 2023 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR SELECTIVE ADSORPTION, BY COUNTRY, 2016 & 2023 (%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR PLASMA (PLASMAPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR PLATELETS (PLATELETPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR LEUKOCYTES (LEUKAPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR LYMPHOCYTES (LYMPH APHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR RBC'S (ERYTHROPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 34. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR BLOOD CENTERS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 35. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR HOSPITALS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 36. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 37. HAEMONETICS: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. HAEMONETICS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. HAEMONETICS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 40. FRESENIUS: NET SALES, 2014-2016 ($MILLION)
FIGURE 41. FRESENIUS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 42. FRESENIUS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 43. TERUMO: NET SALES, 2014-2016 ($MILLION)
FIGURE 44. TERUMO: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 45. TERUMO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 46. ASAHI KASEI: NET SALES, 2014-2016 ($MILLION)
FIGURE 47. ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 48. ASAHI KASEI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 49. HEMACARE: NET SALES, 2014-2016 ($MILLION)
FIGURE 50. HEMACARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 51. HEMACARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 52. KANEKA: NET SALES, 2014-2016 ($MILLION)
FIGURE 53. KANEKA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 54. KANEKA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 55. KAWASUMI: NET SALES, 2014-2016 ($MILLION)
FIGURE 56. KAWASUMI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 57. KAWASUMI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 58. CERUS: NET SALES, 2014-2016 ($MILLION)
FIGURE 59. CERUS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 60. CERUS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 61. B. BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 62. B. BRAUN: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 63. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 64. NIKKISO: NET SALES, 2014-2016 ($MILLION)
FIGURE 65. NIKKISO: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 66. NIKKISO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)